Less Admin. More Research. Better Matches.
TriaLinQ empowers oncology practices to conduct smarter, faster, and more inclusive clinical trials.
Developed by ConcertAI and powered by CancerLinQ, TriaLinQ integrates AI pre-screening, EMR-to-EDC automation, and patient-centric tools into a single, end-to-end platform. Designed for oncology practices, it reduces manual workload, improves data quality, and expands access to clinical research - especially at community and underutilized sites.
Key Benefits of TriaLinQ
Accelerated Recruitment
Identify and enroll the right patients faster, with AI that learns from performance data.
Reduced Site Burden
Eliminate redundant data entry and paperwork with full EMR integration.
Improved Data Quality
Auto-filled eCRFs and built-in compliance tools reduce errors and ensure integrity.
Expanded Access
Bring low-burden trials to more diverse patient populations and underrepresented sites.
Core Capabilities Driving Impact
AI-Enabled Pre-Screening
Find the Right Patients, Faster
- Continuously evaluates all patients with each data refresh
- Uses proven AI models to predict eligibility and rank candidates
- Reduces human bias and improves true positive match rates
- Supports novel therapy matching in near real-time
EMR-to-EDC
One Workflow. Zero Redundancy.
- Seamless integration with EMRs for structured/unstructured data extraction
- Autofills eCRFs to reduce manual data entry and errors
- Enables direct, compliant data capture with GenAI/NLP support
- Improves speed and accuracy of trial data collection
End-to-End Trial Management
From Feasibility to Follow-Up
- Digital study design and feasibility dashboards
- Study startup, eConsent, and low-burden execution tools
- Manages consent forms, ePROs, and quality of life questionnaires
- Tracks participant engagement throughout and beyond the study lifecycle
Designed for Research Sites
Made by—and for—Clinical Teams
- Intuitive software tailored to real research workflows
- Consolidates eligibility evidence for transparent review
- Supports day-to-day operations with automation and insight
- Backed by CancerLinQ’s experience with 600+ oncology sites
Turning Data Into Decisions
How real-world comparisons guide more confident, personalized oncology care - right within the workflow.
Continuous eScreening
evaluates all patient records with every update to surface real-time matches.
Digital study design tools
streamline feasibility, startup, and execution from a single platform.
eConsent and ePROs
simplify patient engagement and capture quality-of-life measures throughout the trial.
AI-enabled matching
improves candidate accuracy, reducing false positives and screen failures.
GenAI + NLP
enables the structured capture of unstructured notes for better, faster data submission.